Home » 23andMe Closes on $22M Series C Funding

23andMe Closes on $22M Series C Funding

Nov 09, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – 23andMe today said that it has closed on its Series C financing, raising more than $22 million.

New investor Johnson & Johnson Development Corp. participated in the round, which also included New Enterprise Associates and Google Ventures, the Mountain View, Calif.-based personal genetics testing firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Dec 01, 2014

23andMe Gets CE Mark, Launches PGS Offering in UK for £125

Jun 20, 2014

FDA Accepts 510(k) Application for 23andMe Health Report on Bloom Syndrome

Nov 04, 2014

23andMe Scientists Offer Closer Look at Ancestry Composition Analysis Tool in New Paper

Premium
Dec 09, 2014

Australian Government Warns for Caution on DTC Genetic Testing

Jul 30, 2014

Illumina Mulls Investments in Array Business, Expects Long-term Growth in Consumer, Ag, IVF Markets

Premium
Dec 02, 2014

23andMe's Health-related DTC Testing Service Aims for Friendlier Reception from UK Regulators

Premium

The Scan

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

What's Popular?

In Clinical & Translational

  1. Study Highlights High False Positive Rate of NIPT for Some Disorders Despite High Specificity

    Premium

  2. Life Technologies Acquires Lung Cancer Test Developer Pinpoint Genomics

  3. ZyGem, Lockheed Martin Aim to Speed Forensic DNA Analysis with Portable, Automated Platform

    Premium

  4. US Supreme Court Hears Arguments For, Against Gene Patents

  5. NMTC's 'Italian Soap Opera' Leaves Luminex Crowing 'Nice Win' While GenMark Cuts Guidance

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.